V. Kiri

First name
V.
Last name
Kiri
Soriano, J. B., Vestbo, J., Pride, N. B., Kiri, V., Maden, C., & Maier, W. C. (2002). Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J.
Watson, L., Kerstjens, H. A., Rabe, K. F., Kiri, V., Visick, G. T., & Postma, D. S. (2005). Obtaining optimal control in mild asthma: theory and practice. Fam Pract. http://doi.org/10.1093/fampra/cmi013
Borghs, S., Thieffry, S., Noack-Rink, M., Dedeken, P., Hong, L. S., Byram, L., et al. (2017). Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study. BMC Neurol. http://doi.org/10.1186/s12883-017-0837-y
Powell, G., Logan, J., Kiri, V., & Borghs, S. (2019). Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records. BMJ Open. http://doi.org/10.1136/bmjopen-2019-032551
Borghs, S., Byram, L., Chan, J., Dedeken, P., Logan, J., Kiri, V., et al. (2020). Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study. BMC Neurol. http://doi.org/10.1186/s12883-019-1587-9